Research Article | Open Access
Lixiang Chen, Xue Liu, Xin Yu, Rongrong Ren, Chao Wang, Rui Zhao, Guangxun Meng, Shun Li, Xiaohui Zhou, "Chlamydia muridarum Infection of Macrophages Stimulates IL-1β Secretion and Cell Death via Activation of Caspase-1 in an RIP3-Independent Manner", BioMed Research International, vol. 2017, Article ID 1592365, 8 pages, 2017. https://doi.org/10.1155/2017/1592365
Chlamydia muridarum Infection of Macrophages Stimulates IL-1β Secretion and Cell Death via Activation of Caspase-1 in an RIP3-Independent Manner
Chlamydiae are Gram-negative bacteria, which replicate exclusively in the infected host cells. Infection of the host cells by Chlamydiae stimulates the innate immune system leading to an inflammatory response, which is manifested not only by secretion of proinflammatory cytokines such as IL-1 from monocytes, macrophages, and dendritic cells, but also possibly by cell death mediated by Caspase-1 pyroptosis. RIP3 is a molecular switch that determines the development of necrosis or inflammation. However, the involvement of RIP3 in inflammasome activation by Chlamydia muridarum infection has not been clarified. Here, we assessed the role of RIP3 in synergy with Caspase-1 in the induction of IL-1β production in BMDM after either LPS/ATP or Chlamydia muridarum stimulation. The possibility of pyroptosis and necroptosis interplays and the role of RIP3 in IL-1 production during Chlamydia muridarum infection in BMDM was investigated as well. The data indicated that RIP3 is involved in NLRP3 inflammasome activation in LPS/ATP-stimulated BMDMs but not in Chlamydia muridarum infection. Pyroptosis occurred in BMDM after LPS/ATP stimulation or Chlamydia muridarum infection. Moreover, the results also illuminated the important role of the Caspase-1-mediated pyroptosis process which does not involve RIP3. Taken together, these observations may help shed new light on details in inflammatory signaling pathways activated by Chlamydia muridarum infection.
Chlamydiae are obligate intracellular Gram-negative bacteria that, each year, are responsible for a considerable number of the eye, genital tract, respiratory tract, vasculature, and joints infections in humans [1, 2]. Despite the threat posed by chlamydial infections to the global public health, the exact molecular mechanism underlying their pathogenesis remains elusive. Since Chlamydia replicate only in the infected host cells, the outcome of infection depends on the interactions of Chlamydia and the host and the balance in the induction of inflammatory and cell death pathways [3–6].
As a potent pyrogen, IL-1 elicits a strong proinflammatory response  and plays a critical role in the clearance or Chlamydia-associated pathology. IL-1 belongs to the IL-1, predominantly proinflammatory, family of cytokines. The production and activation process of the IL-1β family of cytokines requires two signals. Activation of NF-B, resulting from signaling such as TLRs, induces the transcription of IL-1 family cytokines, including pro-IL-1 and pro-IL-18. The second signal which is derived from a wide range of cytosolic complexes of host-cell molecules, known as the inflammasome, leads to activation of the protease Caspase-1 necessary for cleavage of the immature form of IL-1 cytokines [8, 9]. One of the most important inflammasomes consists of NLRP3, ASC, and Caspase-1, which is the key executor processing pro-IL-1, pro- IL-18, and so forth into their mature forms [10, 11].
NLRP3 inflammasome could be activated by a variety of inflammatory triggers, including ATP, microbial toxins, and crystalline substances [12, 13]. Some pathogens such as bacteria, fungi, and viruses could also activate NLRP3 inflammasome . For example, Chlamydia infections could lead to activation of Caspase-1 in monocytes, macrophages, and dendritic cells and associated IL-1 secretion [15–20].
Infection of mice by Chlamydia muridarum gives a similar pathology to that shown in humans and for this reason murine models have been employed to study Chlamydia-associated pathogenesis . Using this animal model, it was demonstrated that Chlamydia muridarum is able to activate Caspase-1 and NLRP3 inflammasome [22–24]. Inflammasome activation results in an inflammatory response and possibly also in cell death attributed to Caspase-1-mediated pyroptosis. It was reported that Chlamydia infection could induce necrosis of infected cells; however, the exact underlying mechanisms remain unknown. Delineating the interaction of inflammation pathways and cell death pathways is critical for understanding chlamydial pathogenesis.
Necrosis with programmed cell death features characterizes chlamydiae infection, but the mechanism has not been revealed. Recently, the receptor-interacting protein kinase 3 (RIP3/RIPK3) has emerged as a critical regulator of programmed necrosis referred to as necroptosis . Caspase-1- or Caspase-11-mediated cell death, or pyroptosis, is dependent on the activation of the inflammasome. Few studies demonstrated the interactions among apoptosis, necrosis, and autophagy; however, the interplay between pyroptosis and necroptosis and the secretion of IL-1β proinflammatory cytokines as well as the signaling molecules that regulate the two cell death pathways remain obscure.
In the present study, employing a murine model of Chlamydia muridarum infection, we investigated the possibility of interplay between pyroptosis and necroptosis in conjunction with the role of RIP3, a key molecule regulating necroptosis pathways and IL-1 production in bone marrow derived macrophages (BMDMs).
2. Materials and Methods
Rip3−/− mice were kindly provided by Prof. Xiaodong Wang’s group, and Caspase-1−/− mice were purchased from Jackson Laboratory. C57BL/6 mice were purchased from B&K Universal Group Limited (Shanghai, China), and Rip3−/−Caspase-1−/− mice were obtained by crossing Rip3−/− and Caspase-1−/− mice. Mice were kept under specific pathogen-free conditions at the Animal Center, Shanghai Public Health Clinical Center. All animal-related procedures were performed according to the Institutional Animal Care and Use Committee (IACUS).
The materials used were as follows: Chlamydia muridarum (C. muridarum, Chlamydia mouse strain Nigg II; ATCC, USA); Iscove’s modified Dulbecco’s medium (IMDM, Gibco); fetal bovine serum (FBS, Gibco, USA); cycloheximide (Sigma-Aldrich, USA); macrophage colony-stimulating factor (m-CSF, PeproTech, USA); penicillin-streptomycin (Gibco, USA); nonessential amino acid (Gibco, USA); LPS (Sigma-Aldrich, USA, cat. number L3012); ATP (Sigma-Aldrich, USA); anti-mouse Caspase-1p20 (Adipogen, USA); anti-rabbit IL-1beta (Sigma-Aldrich, USA); anti-mouse β-actin (Abcam, USA); protease inhibitor (PI, Roche, Switzerland); phosphatase inhibitors (PhosSTOP, Roche, Switzerland); Annexin V-APC (BD, USA); Annexin V-FITC/propidium iodide (PI) assay kit (KeyGen, China); mouse IL-1beta ELISA Ready-Set-Go kit (eBioscience, USA); FAM-FLICA-Caspase-1 kit (AbD Serotec, Switzerland); CytoTox96 Nonradioactive Cytotoxicity Assay (Promega, USA); 2x SDS loading buffer (Tris, 1.21 g; SDS, 4 g; β-mercaptoethanol, 10 ml; glycerol, 20 ml; bromophenol blue, 0.2 g; double distilled water to 1000 ml); lysis buffer (1000 ml: 2x SDS loading buffer, 840 μl; β-mercaptoethanol, 100 μl; PI, 50x, 20 μl; PS, 25x, 40 μl).
2.3. Chlamydial Propagation
BGMK cells were kindly gifted by the University of South China and used for C. muridarum propagation. BGMK cells were infected by C. muridarum, and EBs were purified by gradient centrifugation. The infectivity titers were determined by immunofluorescence quantity analysis. The inclusion-forming units per milliliter were 1 × 109. Cells were cultured in IMDM with 10% FBS and 1% penicillin-streptomycin and maintained in an incubator at 37°C and 5% CO2. Logarithmically growing cells were used for experiments.
2.4. Macrophage Differentiation and Stimulation
Bone marrow cells were harvested from 8- to 12-week-old mice, and they were differentiated into macrophages (bone marrow derived macrophages, BMDMs) by culturing in IMDM containing 40 ng/ml M-CSF, 10% FBS, 1% nonessential amino acid, and 1% penicillin-streptomycin. After six days, BMDMs were seeded into six-well cell culture plates, and on the following day, LPS (50 ng/ml) was added and cultured for 6 hours. At the last thirty minutes of 6 hours, 0.5 M ATP was added. For Chlamydia infection, BMDMs were infected by 10 Multiplicity of Infection (MOI) Chlamydia muridarum for either 12 or 24 hours.
2.5. Western Blotting
Cell supernatants were collected and concentrated by methanol and chloroform. The concentrated precipitation and cells were washed and lysed in lysis buffer. Samples were denatured in loading buffer and boiled at 100°C for 10 minutes. Proteins separated by SDS-PAGE were transferred to nitrocellulose membranes and immunoblotted with primary antibodies against Caspase-1, IL-1β, and β-actin, followed by HRP-conjugated secondary antibodies. ECL reagent was used for western blot development.
2.6. Flow Cytometry and Cell Death Assay
BMDMs, preinfected with C. muridarum or stimulated with LPS and ATP, were stained with Caspase-1 FLICA, and PI or Annexin V for cell death analysis on an LSR II using FlowJo software (BD Biosciences).
2.7. Cytokine Analysis
Mouse IL-1β Ready-Set-Go ELISA kit was used to detect the concentrations of IL-1β cytokines in the cell supernatants.
2.8. Lactate Dehydrogenase (LDH) Release Assay
The quantity of LDH released into the culture medium was detected for evaluating cell membrane disruption using the CytoTox96 Nonradioactive Cytotoxicity Assay kit in accordance with the manufacturer’s instructions.
Data were analyzed by GraphPad Prism 5.0 software and presented as mean ± standard deviation. Student’s -test was used to determine statistical significance. The figures are shown by combining the values of three independent experiments. was considered statistically significant (values = mean ± SE; , , and ).
3.1. NLRP3 Inflammasome Activation Induced by LPS/ATP Stimulation in Macrophage
It is well established that NLRP3 inflammasome is activated following LPS/ATP treatment . To confirm whether the IL-1β secretion is dependent on Caspase-1 activation, the bone marrow cells obtained from C57BL/6 (wild type, WT) mice or Caspase-1−/− mice (C57BL/6 background) were differentiated into bone marrow derived macrophages (BMDMs) using M-CSF. BMDMs were then treated with either PBS, LPS, or LPS/ATP. As expected, IL-1β was detected in culture supernatants of WT but not of Casp-1−/− BMDMs following LPS/ATP stimulation (Figure 1(a)). To further confirm LPS/ATP-mediated activation of NLRP3 inflammasome, the cleavage of IL-1β and Caspase-1 was examined by western blot immunoanalysis. The results show the presence of a mature form of IL-1β and Caspase-1 in supernatants of WT BMDMs following LPS/ATP stimulation (Figures 1(b) and 1(c), resp.).
3.2. The Role of Caspase-1 in the Release of LDH in LPS/ATP-Stimulated BMDMs
We demonstrated activation of NLRP3 inflammasome following LPS/ATP stimulation of BMDMs. Pyroptosis is a form of inflammatory cell death where activation of NLRP3 inflammasome results in the loss of cell membrane integrity and release of lactate dehydrogenase (LDH) that is normally maintained within the cell cytosol. We, therefore, compared whether LPS/ATP stimulation of WT or Caspase-1−/− BMDMs leads to cell death manifested by the release of LDH. Our results show a significant increase in the release of LDH from LPS/ATP-stimulated WT BMDMs compared to Caspase-1−/− BMDM, suggesting occurrence of pyroptosis (Figure 2).
3.3. The Role of RIP3 and Caspase-1 in the Activation of NLRP3 Inflammasome Induced by LPS/ATP Stimulation
RIP3 is an important regulator of programmed necrosis, which can also promote inflammation independent of its pronecrotic activity. To obtain insights into the involvement of RIP3 in the activation of canonical NLRP3 inflammasome, we employed BMDMs generated from RIP3−/−, RIP3−/−Caspase-1−/−, or WT mice followed by stimulation with LPS/ATP or PBS as a control. Secretion of IL-1β to culture supernatants and the presence of the cleaved forms of IL-1β and Caspase-1 were examined in culture supernatants and cell lysates. As shown in Figure 3(a), compared with WT BMDMs, the secretion of IL-1β and the cleavage of IL-1β and Caspase-1 were reduced in RIP3−/− BMDMs, suggesting RIP3 involvement in this process. Moreover, knockout of both RIP3 and Caspase-1 abrogated NLRP3 inflammasome activation after stimulation, underscoring the significant role of Caspase-1 in NLRP3 inflammasome activation (Figures 3(b) and 3(c)). The expression level of Rip3 in WT, Casp-1−/−, Rip3−/−, and Rip3−/−Casp-1−/− BMDMs which were treated with either PBS, LPS, or LPS/ATP was checked by southern blot. The results showed Rip3 in WT and Casp-1−/− BMDMs treated with PBS, LPS, or LPS/ATP having similar expression levels (Figure 4). As we expected, Rip3 expression was not detected in both Rip3−/− and Rip3−/−Casp-1−/− BMDMs (Figure 4).
3.4. The Role of RIP3 in the Release of LDH Induced by LPS/ATP Stimulation
To study the role of RIP3 in BMDMs death following LPS/ATP stimulation, we compared the release of LDH from RIP3−/−, RIP3−/−Casp-1−/−, and WT BMDMs. The results demonstrated similar levels of LDH released from LPS/ATP-stimulated RIP3−/− and WT BMDMs, suggesting that RIP3 is not involved in the cell death induced by LPS/ATP (Figure 5). However, significantly different levels of LDH were released from RIP3−/− and RIP3−/−Caspase-1−/− BMDMs, confirming the important role in the cell death process.
3.5. The Activation of NLRP3 Inflammasome Induced by C. muridarum
We further determined whether C. muridarum infected BMDMs secrete IL-1β and whether this process requires inflammasome-dependent Caspase-1 activation. BMDMs from Caspase-1−/− and WT mice were infected with C. muridarum (MOI = 10) for either 12 hours or 24 hours. We detected IL-1β secretion in culture supernatants (Figure 6(a)) and the cleavage of IL-1β (Figure 6(b)) and Caspase-1 (Figure 6(c)) both in WT BMDM. However, in Caspase-1−/− BMDM, almost no IL-1β secretion and cleavage of IL-1β and Caspase-1 were detected. These results suggest that Caspase-1 plays a significant role in the activation of NLRP3 inflammasome during C. muridarum infection.
3.6. The Role of RIP3 in the Activation of NLRP3 Inflammasome Induced by C. muridarum
Our previous results showed that RIP3 might be involved in the NLRP3 inflammasome activation during LPS/ATP stimulation. We thus examined whether RIP3 could regulate NLRP3 inflammasome activation induced by C. muridarum. Therefore, we infected BMDMs from WT, RIP3−/−, and RIP3−/−Caspase-1−/− mice with C. muridarum (MOI = 10). The results showed that there were no significant differences in IL-1β secretion and Caspase-1 cleavage between RIP3−/− and WT BMDMs (Figure 7(a)). In RIP3−/−Caspase-1−/− BMDMs, nearly no IL-1β secretion and cleavage of IL-1β and Caspase-1 were detected (Figures 7(b) and 7(c)).
3.7. The Role of RIP3 and Caspase-1 in Cell Death Induced by C. muridarum
To examine whether RIP3 and Caspase-1 are involved in cell death induced by C. muridarum, we infected BMDMs from either WT, Caspase-1−/−, RIP3−/−, or RIP3−/−Caspase-1−/− mice with C. muridarum (MOI = 10). Flow cytometry was used for detection of cell death. The results (Figure 8) showed that cell death was increased after C. muridarum infection in the four different sets of BMDMs compared to their corresponding control groups without C. muridarum infection. Compared to the wild type BMDMs, in Caspase-1−/− BMDMs, the ratio of cell death was reduced after C. muridarum infection. However, in the RIP3−/− BMDMs, the ratio of cell death showed no significant differences compared with WT BMDMs after C. muridarum infection. The Caspase-1−/− RIP3−/− BMDMs showed almost similar results to Caspase-1−/− BMDMs compared with WT BMDMs after C. muridarum infection.
NLRP3 inflammasome can be activated by bacterial, fungal, viral, and other agents such as ATP . Previous studies demonstrated that canonical NLRP3 inflammasome activated by LPS/ATP in vitro induces secretion of IL-1β and pyroptosis . We utilized LPS plus ATP, as a PAMP and a DAMP (damage associated molecular pattern), to stimulate either Caspase-1 deficient, RIP3 deficient, or Caspase-1/RIP3 double deficient and WT BMDMs. Stimulation of WT BMDMs with LPS/ATP led to IL-1β secretion and Caspase-1 cleavage indicating activation of the NLRP3 inflammasome and IL-1β cleavage mediated by Caspase-1. In contrast, Caspase-1 deficient and Caspase-1/RIP3 double deficient BMDMs were unable to secrete IL-1β and consequently did not cause Caspase-1 cleavage. However, RIP3 deficient BMDMs were proficient in secretion of IL-1β and in the cleavage of Caspase-1 albeit at reduced rates compared with WT BMDMs. These results prompted us to examine the role of RIP3 in the process of NLRP3 inflammasome activation following LPS/ATP stimulation of BMDMs. Since LPS activates CD14/TLR4 and ATP is known to stimulate the nucleotide receptor P2X7 , we hypothesized that RIP3 may take part in the signaling pathways downstream of TLR4 and P2X7.
Caspase-1 is required for induction of pyroptosis and production of the proinflammatory cytokine IL-1β . Therefore, employing WT and Caspase deficient BMDMs, we investigated the involvement of Caspase-1 in the regulation of cell death following stimulation of BMDMs with LPS/ATP. We demonstrated that Caspase-1 deficient or Caspase-1/RIP3 double deficient BMDMs stimulated with LPS/ATP released significantly lower levels of LDH compared to WT controls. The dominant role of Caspase-1 in the release of LDH is further underscored by the fact that RIP3 deficient BMDMs were able to release the same level of LDH as WT controls. Together, these observations suggest induction of pyroptosis following LPS/ATP stimulation of BMDMs and illuminate the important role Caspase-1 and lack of involvement of RIP3 in this process.
It has been demonstrated that infection of monocytes and macrophages by some strains of Chlamydia, including Chlamydia trachomatis, Chlamydia muridarum, and Chlamydia psittaci, leads to IL-1 secretion consequent to the activation of Caspase-1 . Studies also showed that RIP3 can promote inflammation independent of its pronecrotic activity. However, it is not clear whether, in Chlamydia muridarum infected immune cells, RIP3, alone or synergistically with Caspase-1, is required for IL-1 secretion and is involved in pyroptosis. It has been reported that macrophages mediate crucial innate immune responses via Caspase-1-dependent processing and secretion of IL-1β and IL-18 . To obtain some insights, we used BMDMs with the different backgrounds and studied the impact of Chlamydia muridarum infection on IL-1β secretion and Caspase-1 cleavage. We showed that Chlamydia muridarum infection of WT BMDMs leads to IL-1β secretion and Caspase-1 cleavage, indicating NLRP3 inflammasome activation. In contrast, Caspase-1 deficient and Caspase-1/RIP3 double deficient BMDMs infected with Chlamydia muridarum were incapable of IL-1β secretion and Caspase-1 cleavage, which was in accordance with our results using LPS/ATP stimulation. However, there were no significant differences in IL-1β secretion and Caspase-1 cleavage between RIP3−/− and WT BMDMs after Chlamydia muridarum infection. This result is inconsistent with RIP3−/− BMDMs stimulated with LPS/ATP. We presume that the downstream signaling pathways activated by LPS/ATP stimulation may vary from those engaged by Chlamydia muridarum. Moreover, in Chlamydia muridarum infection, RIP3 may not be involved in NLRP3 inflammasome activation, which is in contrast to what we observed following LPS/ATP stimulation of BMDMs. Currently, four distinct cellular death programs have been identified, namely, apoptosis, necroptosis, autophagy, and pyroptosis [31, 32]. Chlamydia infected cells were reported to be resistant to numerous experimental apoptotic stimuli, exhibiting inhibition of Caspase activation and blockage of cytochrome C release from mitochondria [33, 34]. And it has been reported that Chlamydia lymphogranuloma venereum can strongly induce autophagy in the middle of the chlamydial developmental cycle (24 h after infection), suggesting that autophagy is activated primarily in response to the metabolic stress consequent to chlamydial replication . Miao et al.  reported that Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Employing the flow cytometry analyses, we detected pyroptosis in BMDMs either infected with Chlamydia muridarum or stimulated with LPS/ATP. Our results provide evidence for an important role of Caspase-1 in pyroptosis and a dispensary role of RIP3 in pyroptosis of BMDMs either infected with Chlamydia muridarum or stimulated with LPS/ATP.
In this study, we assessed the role of RIP3 and Caspase-1 and their synergistic function in IL-1β secretion and Caspase-1 cleavage in BMDMs employing two independent systems: LPS/ATP stimulation and Chlamydia muridarum infection. The exact mechanisms or downstream signaling pathways, engaged by Chlamydia muridarum or by LPS/ATP and required for activation of inflammasome, will require further studies. Our studies however provide evidence for the differential role of RIP3 in NLRP3 inflammasome activation in BMDMs following LPS/ATP stimulation or Chlamydia muridarum infection and as such may help to shed new light on details in inflammatory signaling pathways induced by Chlamydia muridarum infection.
Conflicts of Interest
The authors declare that they have no conflicts of interest regarding the publication of this paper.
Lixiang Chen and Xue Liu contributed equally to this work.
This work was supported by the National Natural Science Foundation of China (NSFC, no. 31270217 and no. 81471397), the Natural Science Foundation of Shanghai (NSFS 12ZR1426400), Shanghai Municipal Fund for Science and Technology Development (no. 15140904000), and Fund from Shanghai Public Health Clinical Center (no. 2016-02). The authors would like to thank Dr. Maya Kozlowski for manuscript proofreading and the animal facility in Shanghai Public Health Clinical Center for animal breeding.
- G. I. Byrne and D. M. Ojcius, “Chlamydia and apoptosis: life and death decisions of an intracellular pathogen,” Nature Reviews Microbiology, vol. 2, no. 10, pp. 802–808, 2004.
- A. Nunes and J. P. Gomes, “Evolution, phylogeny, and molecular epidemiology of Chlamydia,” Infection, Genetics and Evolution, vol. 23, pp. 49–64, 2014.
- N. Inohara, M. Chamaillard, C. McDonald, and G. Nuñez, “NOD-LRR proteins: role in host-microbial interactions and inflammatory disease,” Annual Review of Biochemistry, vol. 74, pp. 355–383, 2005.
- F. Martinon and J. Tschopp, “NLRs join TLRs as innate sensors of pathogens,” Trends in Immunology, vol. 26, no. 8, pp. 447–454, 2005.
- L. L. Bourhis and C. Werts, “Role of Nods in bacterial infection,” Microbes and Infection, vol. 9, no. 5, pp. 629–636, 2007.
- T. M. Sager, M. Wolfarth, S. S. Leonard et al., “Role of engineered metal oxide nanoparticle agglomeration in reactive oxygen species generation and cathepsin B release in NLRP3 inflammasome activation and pulmonary toxicity,” Inhalation Toxicology, vol. 28, no. 14, pp. 686–697, 2016.
- L. A. B. Joosten, M. G. Netea, E. Mylona et al., “Engagement of fatty acids with toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis,” Arthritis and Rheumatism, vol. 62, no. 11, pp. 3237–3248, 2010.
- C.-J. Chen, Y. Shi, A. Hearn et al., “MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals,” The Journal of Clinical Investigation, vol. 116, no. 8, pp. 2262–2271, 2006.
- F. Martinon, A. Mayor, and J. Tschopp, “The inflammasomes: guardians of the body,” Annual Review of Immunology, vol. 27, pp. 229–265, 2009.
- B. B. Mishra, V. A. K. Rathinam, G. W. Martens et al., “Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β,” Nature Immunology, vol. 14, no. 1, pp. 52–60, 2013.
- A. K. Mankan, T. Dau, D. Jenne, and V. Hornung, “The NLRP3/ASC/Caspase-1 axis regulates IL-1β processing in neutrophils,” European Journal of Immunology, vol. 42, no. 3, pp. 710–715, 2012.
- M. Lamkanfi and T.-D. Kanneganti, “Nlrp3: an immune sensor of cellular stress and infection,” International Journal of Biochemistry and Cell Biology, vol. 42, no. 6, pp. 792–795, 2010.
- P. Gurung, P. K. Anand, R. K. S. Malireddi et al., “FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes,” Journal of Immunology, vol. 192, no. 4, pp. 1835–1846, 2014.
- A. G. Hise, J. Tomalka, S. Ganesan et al., “An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans,” Cell Host & Microbe, vol. 5, no. 5, pp. 487–497, 2009.
- A. A. Abdul-Sater, N. Saïd-Sadier, E. V. Padilla, and D. M. Ojcius, “Chlamydial infection of monocytes stimulates IL-1β secretion through activation of the NLRP3 inflammasome,” Microbes and Infection, vol. 12, no. 8-9, pp. 652–661, 2010.
- M. Hvid, A. Baczynska, B. Deleuran et al., “Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection,” Cellular Microbiology, vol. 9, no. 12, pp. 2795–2803, 2007.
- G. Entrican, R. Wilkie, P. Mcwaters, J.-P. Scheerlinck, P. R. Wood, and J. Brown, “Cytokine release by ovine macrophages following infection with Chlamydia psittaci,” Clinical and Experimental Immunology, vol. 117, no. 2, pp. 309–315, 1999.
- A. Gervassi, M. R. Alderson, R. Suchland, J. F. Maisonneuve, K. H. Grabstein, and P. Probst, “Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection,” Infection and Immunity, vol. 72, no. 12, pp. 7231–7239, 2004.
- D. M. Ojcius, P. Souque, J.-L. Perfettini, and A. Dautry-Varsat, “Apoptosis of epithelial cells and macrophages due to infection with the obligate intracellular pathogen Chlamydia psittaci,” Journal of Immunology, vol. 161, no. 8, pp. 4220–4226, 1998.
- C. D. Rothermel, J. Schachter, P. Lavrich, E. C. Lipsitz, and T. Francus, “Chlamydia trachomatis-induced production of interleukin-1 by human monocytes,” Infection and Immunity, vol. 57, no. 9, pp. 2705–2711, 1989.
- T. W. Cotter and G. I. Byrne, “Immunity to Chlamydia: comparison of human infections and murine models,” Research in Immunology, vol. 147, no. 8-9, pp. 587–595, 1996.
- D. Prantner, T. Darville, J. D. Sikes et al., “Critical role for interleukin-1β (IL-1β) during Chlamydia muridarum genital infection and bacterial replication-independent secretion of IL-1β in mouse macrophages,” Infection and Immunity, vol. 77, no. 12, pp. 5334–5346, 2009.
- H. Lu, C. Shen, and R. C. Brunham, “Chlamydia trachomatis infection of epithelial cells induces the activation of caspase-1 and release of mature IL-18,” Journal of Immunology, vol. 165, no. 3, pp. 1463–1469, 2000.
- W. Cheng, P. Shivshankar, Z. Li, L. Chen, I.-T. Yeh, and G. Zhong, “Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection,” Infection and Immunity, vol. 76, no. 2, pp. 515–522, 2008.
- K. Moriwaki and F. K. Chan, “RIP3: a molecular switch for necrosis and inflammation,” Genes and Development, vol. 27, no. 15, pp. 1640–1649, 2013.
- C. Chen, S. Tsai, C. Lu et al., “Activation of an NLRP3 inflammasome restricts Mycobacterium kansasii infection,” PLoS ONE, vol. 7, no. 4, Article ID e36292, 2012.
- Z. Hu, T. Murakami, K. Suzuki et al., “Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism,” PLoS ONE, vol. 9, no. 1, Article ID e85765, 2014.
- M. Triantafilou and K. Triantafilou, “Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster,” Trends in Immunology, vol. 23, no. 6, pp. 301–304, 2002.
- T. Fernandes-Alnemri, J. Wu, J.-W. Yu et al., “The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation,” Cell Death and Differentiation, vol. 14, no. 9, pp. 1590–1604, 2007.
- E. A. Miao, I. A. Leaf, P. M. Treuting et al., “Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria,” Nature Immunology, vol. 11, no. 12, pp. 1136–1142, 2010.
- L. Cabon, A.-C. Martinez-Torres, and S. A. Susin, “Programmed cell death comes in many flavors,” Medecine/Sciences, vol. 29, no. 12, pp. 1117–1124, 2013.
- B. Song, T. Zhou, W. Yang, J. Liu, and L. Shao, “Programmed cell death in periodontitis: recent advances and future perspectives,” Oral Diseases, 2016.
- K. Rajalingam, H. Al-Younes, A. Müller, T. F. Meyer, A. J. Szczepek, and T. Rudel, “Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis,” Infection and Immunity, vol. 69, no. 12, pp. 7880–7888, 2001.
- K. Rajalingam, M. Sharma, C. Lohmann et al., “Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells,” PLoS ONE, vol. 3, no. 9, Article ID e3102, 2008.
- N. Pachikara, H. Zhang, Z. Pan, S. Jin, and H. Fan, “Productive Chlamydia trachomatis lymphogranuloma venereum 434 infection in cells with augmented or inactivated autophagic activities,” FEMS Microbiology Letters, vol. 292, no. 2, pp. 240–249, 2009.
Copyright © 2017 Lixiang Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.